-
2023.08.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
-
2023.08.01
Articles of Association
-
2023.07.07
EARLY FEASIBILITY STUDY OF LUX-VALVE PLUS PRE-SUBMISSION ACCEPTED BY THE FDA
-
2023.07.05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
-
2023.06.05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
-
2023.05.31
POLL RESULTS OF THE 2022 ANNUAL GENERAL MEETING HELD ON MAY 31, 2023
-
2023.05.16
POLL RESULTS OF THE 2023 FIRST EXTRAORDINARY GENERAL MEETING, THE 2023 FIRST CLASS MEETING OF H SHAREHOLDERS AND THE 2023 FIRST CLASS MEETING OF DOMESTIC SHAREHOLDERS AND UNLISTED FOREIGN SHAREHOLDERS
-
2023.05.05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
-
2023.04.25
PROXY FORM FOR THE 2022 ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, MAY 31, 2023
-
2023.04.25
NOTICE OF 2022 ANNUAL GENERAL MEETING